End-Stage Kidney Disease
58
6
10
29
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.7%
1 terminated out of 58 trials
96.7%
+10.1% vs benchmark
17%
10 trials in Phase 3/4
10%
3 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 29 completed trials
Clinical Trials (58)
Incremental Hemodialysis: The TwoPlus Trial
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Assessment of Left Ventricular Myocardial Dysfunction in Children With End-Stage Kidney Disease Using Two-Dimensional and Three-Dimensional Speckle-Tracking Echocardiography
Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration
The Arteriovenous Vascular (AV) ACCESS Trial
Exercise and Cardiac Stunning During HD
Nocturnal APD vs. CAPD in Non-diabetic ESKD
Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag)
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients
Symptom Management in Patients on Dialysis
Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Applications of MRI in Kidney Disease